Preformulation stability of Spantide II, a promising topical anti-inflammatory agent for the treatment of psoriasis and contact dermatitis

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 1, 2004, Pages 19-25

  Kikwai, Loice ^a   Babu, R J ^a   Kanikkannan, Narayanasamy ^a   Singh, Mandip ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ALCOHOL; ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT; DIETHYLENE GLYCOL MONOETHYL ETHER; LAURIC ACID DERIVATIVE; LAUROGLYCOL; LYSINE; MYRISTIC ACID ISOPROPYL ESTER; OLEIC ACID; OLEIC ACID ETHYL ESTER; PIPERAZINEDIONE; PROLINE; PROPYLENE GLYCOL; PROPYLENE GLYCOL LAURATE; SODIUM CHLORIDE; SPANTIDE II; UNCLASSIFIED DRUG;

ALPHA HELIX; AQUEOUS SOLUTION; ARTICLE; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); CONTACT DERMATITIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG STABILITY; EVIDENCE BASED MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PH; PREFORMULATION; PROTEIN DEGRADATION; PSORIASIS; TEMPERATURE;

EID: 1042269561     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2004.tb02573.x     Document Type: Article

References (23)

1. Andoh, T., Nagasawa, T., Satoh, M., Kuraishi, Y. (1998) Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J. Pharmacol. Exp. Ther. 286: 1140-1145
2. Ansel, J. C., Kaynard, A. H., Armstrong, C. A., Olerud, J. E., Bunnett, K. W., Payan, D. G. (1996) Skin-nervous system interactions. J. Invest. Dermatol. 106: 198-204
3. Ansel, J. C., Armstrong, C. A., Song, I., Quinlan, K. L., Olerud, J. E., Caughman, S. W., Bunnett, N. W. (1997) Interactions of the skin and nervous system. J. Invest. Dermatol. Symp. Proc. 2: 23-26
4. Brain, S. D. (1996) Sensory neuropeptides in the skin. In: Geppeti, P. Holzer, P. (eds) Neurogenic Inflammation. CRC Press, Boca Raton, pp 229-244
5. Brange, J., Langkjaer, L., Havelund, S., Volund, A. (1992) Chemical stability of insulin 1. Hydrolytic degradation during storage of pharmaceutical preparation. Pharm. Res. 9: 715-726
6. Brown, J. R., Perry, P., Hefeneider, S., Ansel, A. C. (1990) Neuropeptide modulation of keratinocyte cytokine production. In: Oppenheim, P., Kluger, D., (eds) Molecular and Cellular Biology of Cytokines. Wiley-Liss Inc., New York, pp 451-456
7. Bummer, P. M., Koppenol, S. (2000) Chemical and physical considerations in protein and peptide stability. In: McNally, E. J. (ed.) Protein Formulation and Delivery. Marcel Dekker Inc., New York, pp 5-70
8. Epstein, N. N., Epstein, W. L., Epstein, J. H. (1963) Atrophic striae in patients with inguinal intertrigo. Arch. Dermatol. 87: 450-457
9. Goolcharran, C., Borchardt, R. T. (1998) Kinetics of diketopiperazine formation using model peptides. J. Pharm. Sci. 87: 283-288
10. Helm, V. J., Muller, B. W. (1991) Stability of the synthetic pentapeptide thymopentin in aqueous solution: Effect of pH and buffer on degradation. Int. J. Pharm. 70: 29-34
11. Holzwarth, G., Dotz, P. (1965) The ultraviolet circular dichroism of polypeptides. J. Am. Chem. Soc. 178: 350-355
12. Jaiani, L. T., Sachdeva, M., Jaychandra, B. R., Kanikkannan, N., Legat, F. J., Neparidze, N. G., Kikwai, L., Armstrong, C. A., Ansel, J. C. (2002) Inhibition of allergic contact dermatitis by a topically applied SP receptor antagonist. J. Invest. Dermatol. 119: 655
13. Kohn, W. D., Kay, C. M., Hodges, R. S. (1997) Salt effects on protein stability: Two-stranded alpha helical coiled-coils containing inter- or intrahelical ion pairs. J. Mol. Biol. 257: 1039-1052
14. Lee, K. C., Lee, Y. J., Song, H. M., Chun, C. J., Deluca, P. P. (1992) Degradation of synthetic salmon calcitonim in aqueous solution. Pharm. Res. 9: 1521-1523
15. Manning, M. C., Patel, K., Borchardt, R. T. (1989) Stability of protein pharmaceuticals. Pharmacol. Res. 6: 903-918
16. Mycek, M. J., Harvey, R., Champe, P. (1992) Anti-inflammatory drugs. In: Harvey, R. A., Champe, P. C. (eds) Lippincotts Illustrated Reviews: Pharmacology, 2nd edn, Lippincott-Raven, Philadelphia, pp 401-418
17. Robertson, D. B., Maibach, H. I. (1989) In: Schleimer, R. P., Claman, H. N., Oronsky, A (eds) Anti-inflammatory Steroid Action. Academic Press, San Diego, pp 494-524
18. Schimid, R. D. (1970) Stabilized soluble enzymes. Adv. Biochem. Eng. 12: 41-118
19. Scholzen, T., Armstrong, C. A., Bunnett, N. W., Lunger, T. A., Olerud, J. E., Ansel, J. C. (1998) Neuropeptides in the skin: Interactions between the neuroendocrine and the skin immune systems. Exp. Dermatol. 7: 81-96
20. Takeda, K., Arase, S., Takahashi, S. (1988) Side effects of topical corticoids and their prevention. Drugs 36 (Suppl. 5): 15-23
21. Wang, W. (1999) Instability, stabilization and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185: 129-188
22. Wang, Z. Y., Feng, D. M., Wang, Y. L, Tung, S. R., Wong, K., Strichartz, G. R., Folkers, K., Hakanson, R. (1994) Pharmacological assessment of Spantide II analogues. Eur. J. Pharmacol. 260: 121-128
23. Xu, X. J., Hao, J. X., Wiesenfeld-Hallin, Z., Håkanson, R., Folkers, K., Hökfelt, T. (1991) Spantide II, a novel tachykinin antagonist, and galanin inhibits plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw. Neuroscience 42: 731-737